Navigation Links
Questcor to Initiate Pilot Commercialization Effort In Pulmonology for Symptomatic Sarcoidosis
Date:7/11/2013

om respiratory manifestations of symptomatic sarcoidosis will follow the model we have used successfully for these other markets as we continue to explore the full therapeutic potential of Acthar."

"We are experiencing solid uptake of Acthar in rheumatology including, most recently, a larger than expected number of prescriptions for rheumatoid arthritis, an additional on-label indication, and are receiving positive feedback from physicians in the rheumatology community," commented Steve Cartt, Chief Operating Officer of Questcor.  "Based on this early success, and our track record of successful entry into multiple new Acthar markets, we are accelerating our plans to begin a pilot effort for Acthar with pulmonologists to help patients suffering from symptomatic sarcoidosis.  We will hire a small group of new Acthar Specialists to begin calling on and educating pulmonologists about Acthar and its potential role in the treatment of this difficult-to-treat autoimmune disorder.  As we have successfully done in the past with our MS, NS and rheumatology commercial efforts, we expect to gain valuable information from this initial pilot effort, which will inform our potential next steps in the commercialization process."

About Sarcoidosis

More commonly affecting young adults, sarcoidosis is a systemic inflammatory disease where cell nodules or granulomas can manifest in multiple organs, most often in the lungs.  There are about 150,000 diagnosed sarcoidosis patients in the U.S., of which approximately 90% have some degree of pulmonary involvement. 

Sarcoidosis can be difficult to treat, and if not treated successfully, serious health issues can develop, including lung scarring, fibrosis and infections, which may lead to respiratory deterioration and eventual failure. Between 30,000
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
2. Questcor to Report Second Quarter Results on July 24, 2012
3. Questcor Reports Second Quarter Financial Results
4. Questcor Pharmaceuticals to Present at Investor Conferences in September
5. Questcor and The Myositis Association Team Up To Support Research and Educational Initiatives in Polymyositis and Dermatomyositis
6. Questcor Comments on Insurance Policy Bulletin
7. Questcor to Conduct Conference Call to Discuss Reimbursement Process
8. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
9. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
10. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
11. Questcor to Report Fourth Quarter and Full Year 2012 Financial Results on February 26, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... India , September 17, 2014 ... antagonist, GRC 17536, has shown positive data in a ... painful diabetic neuropathy , Glenmark ... Receptor Potential Ankyrin 1 (TRPA1) antagonist, GRC 17536 has ... placebo controlled, multi-centre, proof of concept study conducted on ...
(Date:9/17/2014)... , Sept. 17, 2014  Members of ... and Interventional Associates announced today that the ... to enhance its image sharing capabilities and provide ... any network failures. In addition, the Dicom Systems ... navigate disparate PACS systems to more effectively deliver ...
(Date:9/17/2014)... Sept. 17, 2014 An analysis done by ... taking Sovaldi® (sofosbuvir), a new and expensive treatment for ... over the last several months (May through August 2014) ... in Sovaldi utilization. This suggests another surge of patients ... regimens of similar efficacy and shorter duration are introduced ...
Breaking Medicine Technology:Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 3Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 2Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 3CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 2CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 3CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 4
... United States Environmental Protection Agency (EPA) announced today a ... will be screened as part of EPA,s ToxCast initiative. ... this year, involves the application of extensive and diverse ... very pleased with our contributions to ToxCast to date, ...
... Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) reports ... and Sun Pharma Global, Inc ("Sun Global") for a going ... more of their affiliates would acquire all of the outstanding ... Sun Global for a per share consideration of $4.75 in ...
Cached Medicine Technology:Odyssey Thera to Participate in Expanded EPA Initiative 2Caraco Receives Sun Pharma Proposal to Purchase All Outstanding Shares 2Caraco Receives Sun Pharma Proposal to Purchase All Outstanding Shares 3
(Date:9/18/2014)... (September 18, 2014) Cardiovascular disease is the leading ... a major role in accelerating its progression. Medical ... to decrease cholesterol-carrying lipoproteins such as small dense ... new study, out today in the Journal ... rosuvastatin may be more effective among prediabetic patients ...
(Date:9/18/2014)... 2014 On August 23, the ... with the Distinguished Service Award for his contributions to ... 2014 National Basketball Retired Players Association (NBRPA) Legends World ... the Chicago Bulls in 1977, Glenn would go on ... Knicks, the Atlanta Hawks, and the Milwaukee Bucks throughout ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 One Week Kitchens ... at the Bloomsburg Fair beginning this Saturday. Their display will ... a great example of the products and design services that ... and various countertops for fair-goers to see. This display won ... Show earlier this year and really is something to see. ...
(Date:9/18/2014)... Demand for competency-based education (CBE) is ... routes to job placement and employers expect graduates to ... at a better time as the economy grows and ... in collaboration with employers, career educators and competency-based education ... CBE implementation and direct assessment of learning outcomes. ...
(Date:9/18/2014)... MA (PRWEB) September 18, 2014 ... its team and surgeon partners in Less Exposure ... joining SpineFrontier, Tamara authored an extensive education curriculum ... a Masters in Science in Organizational Leadership, and ... industries for eleven years. Bringing her to the ...
Breaking Medicine News(10 mins):Health News:The HearStrong Foundation Recognizes Mike “Stinger” Glenn with the Distinguished Service Award at the 2014 Legends World Sports Conference 2Health News:The HearStrong Foundation Recognizes Mike “Stinger” Glenn with the Distinguished Service Award at the 2014 Legends World Sports Conference 3Health News:One Week Kitchens Taking Display to Bloomsburg Fair 2Health News:Wonderlic Unites Employers, Career Educators and Competency-Based Education Experts to Help Narrow Skills Gap 2Health News:SpineFrontier Inc. Makes Bold Move to Expand Its Internal Training Team to Collaborate With The LESSociety’s Less Exposure Surgery® University To Educate Surgeons. 2
... , , LOS ANGELES, Dec. ... lives. In a decade, like so many in the preceding century ... been uncounted lives saved . Narconon is certainly ... year out, to save lives. We congratulate the selfless staffs of ...
... working on genetic puzzle to try to save the mammals ... a better understanding of an outbreak of cancerous tumors that ... new report. , Devil facial tumor disease, a kind of ... other physical contact, is one of only two types of ...
... that condition is unavoidable, expert says , THURSDAY, Dec. 31 ... stave off frailty among the elderly. , The notion is ... old that tracked the activities of over 1,000 physically active ... reasonably high-functioning. , Those who spent time volunteering were ...
... ... Online Marketing. We,ve seen a restaurant chain launched promotion that sold out in 90 minutes ... ... downturn of 2009 and closed, there were a handful that took the path less beaten ...
... , WARMINSTER, Pa., Dec. 31 ... leading home gardening company, reports brisk sales for its recently launched, ... containing different varieties for home gardeners who want to make New ... ) , The giant seedpack contains varieties of vegetables and flowers ...
... 31 The following is a statement of Matthew L. ... http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) , North Carolina on January 2 will ... first major tobacco-growing state to implement a statewide smoke-free law ... will protect the right of North Carolinians to breathe clean ...
Cached Medicine News:Health News:Narconon Salutes Its 1,200 Staff Worldwide on 13,000 Lives Saved This Last Decade 2Health News:Narconon Salutes Its 1,200 Staff Worldwide on 13,000 Lives Saved This Last Decade 3Health News:Clues to Cancer That Could Wipe Out Tasmanian Devils 2Health News:Volunteering May Keep Elderly Stronger 2Health News:Volunteering May Keep Elderly Stronger 3Health News:Small Businesses In Singapore Outmarkets & Outperforms Bigger Players in Tough Economy With Online Marketing 2Health News:New Year's Resolution Garden Growing Sales for Burpee 2Health News:North Carolina Goes Smoke-Free on Jan. 2 in Historic Step for Health 2Health News:North Carolina Goes Smoke-Free on Jan. 2 in Historic Step for Health 3
The Biopro Cox comb cup is manufactured from titanium and is porous coated on the outside of the shell. The Cox comb cup accommodates a polyethylene insert....
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
The Trilogy system builds on the success of the Harris/Galante Porous and HGP II cups by combining proven features with new technology designed to inhibit the formation and migration of polyethylene ...
For primary and revision cases...
Medicine Products: